Published in Obesity and Diabetes Week, February 20th, 2006
According to recent research published in the Journal of Pharmacy and Pharmacology, "We have evaluated the antidiabetic effect of S-8300 (a peptide extracted from shark liver (Squalus mitsukurii)) in streptozocin (streptozotocin)-diabetic mice."
F.J. Huang and colleagues working with the China Pharmaceutical University described, "Diabetes was induced by a single intravenous injection of streptozocin (150 mg/kg1). The effects of S-8300 (3 or 10 mg/kg1) on diabetic mice were investigated...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.